Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.
Paul C. Nagle, BSBA
Advertisement
Articles by Paul C. Nagle, BSBA
Advertisement
Latest Updated Articles
- Characteristics of and Trends in the Late-stage Biopharmaceutical Pipeline
Published: April 15th 2008 | Updated:
- Review of Recent US Cost Estimates of Revascularization
Published: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
5
